IN8bio, Inc. - Common Stock (INAB)
0.2558
+0.0079 (3.19%)
In8Bio Inc is a biotechnology company focused on developing innovative therapies for cancer treatment
The company specializes in the advancement of cell-based therapies, particularly utilizing T cell engineering to target and eliminate cancer cells. By harnessing the power of the immune system, In8Bio aims to create effective and personalized treatment options for patients with various types of malignancies. Their research and development efforts are centered around developing cutting-edge approaches that enhance the efficacy and safety of immunotherapies, contributing to the evolving landscape of cancer treatment.
Frequently Asked Questions
Is IN8bio, Inc. - Common Stock publicly traded?
Yes, IN8bio, Inc. - Common Stock is publicly traded.
What exchange does IN8bio, Inc. - Common Stock trade on?
IN8bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for IN8bio, Inc. - Common Stock?
The ticker symbol for IN8bio, Inc. - Common Stock is INAB on the Nasdaq Stock Market
What is the current price of IN8bio, Inc. - Common Stock?
The current price of IN8bio, Inc. - Common Stock is 0.2558
When was IN8bio, Inc. - Common Stock last traded?
The last trade of IN8bio, Inc. - Common Stock was at 4:00 pm EST on January 31st, 2025